RGNX - REGENXBIO Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.4B
Enterprise Value 31.04B
Trailing P/E N/A
Forward P/E 164.27
PEG Ratio (5 yr expected) 1-10.09
Price/Sales (ttm)25.45
Price/Book (mrq)2.82
Enterprise Value/Revenue 318.99
Enterprise Value/EBITDA 6-11.91

Trading Information

Stock Price History

Beta (3Y Monthly) 1.39
52-Week Change 3-43.77%
S&P500 52-Week Change 34.18%
52 Week High 381.40
52 Week Low 330.38
50-Day Moving Average 337.77
200-Day Moving Average 347.75

Share Statistics

Avg Vol (3 month) 3574.04k
Avg Vol (10 day) 3774.06k
Shares Outstanding 536.81M
Float 28.79M
% Held by Insiders 115.70%
% Held by Institutions 183.65%
Shares Short (Aug 15, 2019) 43.84M
Short Ratio (Aug 15, 2019) 46.55
Short % of Float (Aug 15, 2019) 413.60%
Short % of Shares Outstanding (Aug 15, 2019) 410.44%
Shares Short (prior month Jul 15, 2019) 43.89M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin -88.57%
Operating Margin (ttm)-169.66%

Management Effectiveness

Return on Assets (ttm)-13.45%
Return on Equity (ttm)-11.97%

Income Statement

Revenue (ttm)54.85M
Revenue Per Share (ttm)1.53
Quarterly Revenue Growth (yoy)-80.30%
Gross Profit (ttm)124.99M
EBITDA -87.44M
Net Income Avi to Common (ttm)-48.58M
Diluted EPS (ttm)-1.36
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)341.5M
Total Cash Per Share (mrq)9.28
Total Debt (mrq)6.93M
Total Debt/Equity (mrq)1.40
Current Ratio (mrq)14.58
Book Value Per Share (mrq)13.46

Cash Flow Statement

Operating Cash Flow (ttm)-76.74M
Levered Free Cash Flow (ttm)-52.32M